{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:02:21Z","timestamp":1791414141239,"version":"4.3.3"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.ijantimicag.2014.09.011","type":"journal-article","created":{"date-parts":[[2014,10,18]],"date-time":"2014-10-18T15:31:26Z","timestamp":1413646286000},"page":"76-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["In vitro bactericidal activity of aminoglycosides, including the next-generation drug plazomicin, against Brucella spp."],"prefix":"10.1016","volume":"45","author":[{"given":"Steven C.","family":"Olsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve A.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2014.09.011_bib0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(06)70382-6","article-title":"The new global map of human brucellosis","volume":"6","author":"Pappas","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2014.09.011_bib0010","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.ijantimicag.2010.06.015","article-title":"Update on brucellosis: therapeutic challenges","volume":"36","author":"Solera","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.09.011_bib0015","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1371\/journal.pmed.0040317","article-title":"Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations","volume":"4","author":"Ariza","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijantimicag.2014.09.011_bib0020","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1086\/318503","article-title":"Azithromycin and gentamicin therapy for the treatment of humans with brucellosis","volume":"32","author":"Solera","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.09.011_bib0025","first-page":"1","volume":"740","author":"Joint FAO\/WHO expert committee on brucellosis","year":"1986","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.ijantimicag.2014.09.011_bib0030","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1128\/AAC.00678-12","article-title":"Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components","volume":"56","author":"Barnhill","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.09.011_bib0035","first-page":"1","article-title":"Aminoglycoside-induced cochlear pathology in man","volume":"383","author":"Johnsson","year":"1981","journal-title":"Acta Otolaryngol Suppl"},{"key":"10.1016\/j.ijantimicag.2014.09.011_bib0040","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/ki.1988.83","article-title":"Aminoglycoside nephrotoxicity","volume":"33","author":"Humes","year":"1988","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijantimicag.2014.09.011_bib0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/eri.12.25","article-title":"Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin","volume":"10","author":"Zhanel","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2014.09.011_bib0050","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jac\/dkl393","article-title":"Bactericidal agents in the treatment of MRSA infections\u2014the potential role of daptomycin","volume":"58","author":"French","year":"2006","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914003021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914003021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T11:57:05Z","timestamp":1538135825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857914003021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0924857914003021"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.09.011","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro bactericidal activity of aminoglycosides, including the next-generation drug plazomicin, against Brucella spp.","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and the International Society of Chemotherapy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}